Lung Abscess
6
2
3
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
5 treatments under study, led by Avelox Moxifloxacin Bay128039
Research Leaders
6 sponsors active, led by Pfizer
Related Conditions
Often studied with 6 related conditions
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
0.0%
0 terminated out of 6 trials
100.0%
+13.4% vs benchmark
17%
1 trials in Phase 3/4
50%
1 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (6)
Transthoracic Drainage of Lung Abscesses. A National Randomized Trial.
Biomarkers for Diagnosis of Lung Nodules
Evaluation of Different Sizes of Left-Sided Double-Lumen Tubes for Thoracic Surgery in a Tertiary Level Teaching Hospital
Complicated Pneumonia (CP) in Children in South-East Europe
Special Use-Result Surveillance of Unasyn-S (Kit) for Intravenous Use - A Surveillance on High-dose (>6 g Daily) Administration -
BAY12-8039, iv/Oral Pulmonary Abscess/Aspiration Pneumonia
Research Network
Common Treatments
- Avelox Moxifloxacin Bay1280391
- Sulbactamampicillin1
- Intubation Of Patients Undergoing Thoracic Surgery With Left Sided Double Lumen Tube1
- Sulbactam Sodiumampicillin Sodium1
- Transthoracic Drainage1
Active Sponsors
- Pfizer1
- Aleksandar Sovtic1
- University of Aarhus1
- Bayer1
- University of Colorado, Denver1
Top Investigators
University of Colorado, Denver
Related Conditions
- Pneumonia Necrotizing1
- Pneumonia1
- Empyema Pleural1
- Peritonitis1
- Lung Adenocarcinoma1